Oxygen therapy and myocardial ischaemia during exercise testing
A double blind randomised controlled cross-over trial of the effect of high flow oxygen on myocardial ischaemia during exercise treadmill testing (ETT)
Dr Mark Simmonds
20 participants
Apr 13, 2007
Interventional
Conditions
Summary
It is routine clinical practice to administer high flow oxygen to all patients with a heart attack. However, there is evidence to suggest that this approach may be harmful, particularly to those patients who are not hypoxic. High flow oxygen causing hyperoxia has been shown to increase blood pressure and reduce cardiac output, and possibly also reduce coronary artery blood flow. As a result it is crucial that the effects of high flow oxygen on myocardial ischaemia is investigated further in patients with ischaemic heart disease. A double-blind randomised controlled cross-over trial using exercise treadmill testing is an ideal method to measure the effect of supplementary oxygen on myocardial ischaemia.
Eligibility
Plain Language Summary
Simplified for easier understanding
This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients will receive two oxygen regimes in a cross over fashion: room air (placebo) for 5 minutes before the start and continued until the end of the ETT, and high flow oxygen (15/L minute) (comparator) via a non-rebreather mask for 5 minutes before the start and continued until the end of the ETT. The order that the regimes are received will be allocated randomly and there will be approximately 90 minutes between tests. Exercise will be standardised according to the Bruce protocol for exercise stress tests. The ETT will be stopped for any of the following reasons ST elevation, LBBB or arrhythmia occurs The patient requests to stop the test The development of diagnostic ECG ischaemia for 15 seconds The cardiology registrar determines that the ETT should be stopped If none of these endpoints are reached then the duration of the ETT will be determined by the exercise capacity of the patient.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12607000202460